← Leaderboards
Dipen M. Maru
University Of Tx Md Anderson Can Ctr
$1,646,764
Attributed
$2,520,954
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $618.2K · FY2018–23$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,520,954 · 4
By mechanism
P50$1,355,367 · 2
UH3$787,854 · 1
UH2$377,733 · 1
Top collaborators
- Scott Kopetz5 shared
- Rajyalakshmi Luthra5 shared
- Jeffrey S. Morris5 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Scott Kopetz$13,199,822
- Eduardo Vilar Sanchez$16,310,319
- Lauren Averett Byers$9,117,683
- Steven M Kornblau$5,167,204
- Don Lynn Gibbons$4,258,623
Others in their field
Other Emerging Leaders on “Specimen”
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,933,652
- Lynn Briscoe · Leidos Biomedical Research, Inc.$43,388,445
- Julie Ake · National Institute Of Allergy And Infectious Diseases$39,792,120
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$38,341,452
Research focus
SpecimenParaffin EmbeddingFreezingSamplingValidationQuality ControlFormalinGrantLaboratoriesResearch PersonnelTumorBiological MarkersColorectal CancerStandard Of CareClia CertifiedClinical TrialsEnsureEnrollmentBaseCustomBiopsyColorectalApoptosisClosure By Clamp
Grant awards (10)
Core 1: Biospecimen and Pathology Core$274,128
P50 · FY2023 · CA · contact PI
Colorectal Cancer Molecular Subtype Assay Development and Validation$149,772
UH3 · FY2023 · CA · contact PI
Colorectal Cancer Molecular Subtype Assay Development and Validation$340,987
UH3 · FY2022 · CA · contact PI
Core 1: Biospecimen and Pathology Core$277,212
P50 · FY2022 · CA · contact PI
Colorectal Cancer Molecular Subtype Assay Development and Validation$297,095
UH3 · FY2021 · CA · contact PI
Core 1: Biospecimen and Pathology Core$248,431
P50 · FY2021 · CA · contact PI
Core 1: Biospecimen and Pathology Core$280,942
P50 · FY2020 · CA · contact PI
Core 1: Biospecimen and Pathology Core$274,654
P50 · FY2019 · CA · contact PI
Colorectal Cancer Molecular Subtype Assay Development and Validation$163,706
UH2 · FY2019 · CA · contact PI
Colorectal Cancer Molecular Subtype Assay Development and Validation$214,027
UH2 · FY2018 · CA · contact PI